NO20032143L - Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler - Google Patents

Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler

Info

Publication number
NO20032143L
NO20032143L NO20032143A NO20032143A NO20032143L NO 20032143 L NO20032143 L NO 20032143L NO 20032143 A NO20032143 A NO 20032143A NO 20032143 A NO20032143 A NO 20032143A NO 20032143 L NO20032143 L NO 20032143L
Authority
NO
Norway
Prior art keywords
molecules
production process
recombinant dna
large scale
scale production
Prior art date
Application number
NO20032143A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032143D0 (no
Inventor
Rolf-Guenter Werner
Friedrich Goetz
Chatchei Tayapiwatana
Jiradej Manosroi
Aranya Manosroi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20032143D0 publication Critical patent/NO20032143D0/no
Publication of NO20032143L publication Critical patent/NO20032143L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
NO20032143A 2000-11-14 2003-05-13 Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler NO20032143L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027779.8A GB0027779D0 (en) 2000-11-14 2000-11-14 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
PCT/EP2001/012857 WO2002040650A2 (en) 2000-11-14 2001-11-07 Methods for large scale production of recombinant dna-derived tpa or k2s molecules

Publications (2)

Publication Number Publication Date
NO20032143D0 NO20032143D0 (no) 2003-05-13
NO20032143L true NO20032143L (no) 2003-07-07

Family

ID=9903153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032143A NO20032143L (no) 2000-11-14 2003-05-13 Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler

Country Status (31)

Country Link
EP (1) EP1407030B1 (de)
JP (1) JP2004520018A (de)
KR (1) KR100856346B1 (de)
CN (1) CN100567495C (de)
AR (1) AR031334A1 (de)
AT (1) ATE504652T1 (de)
AU (2) AU2181502A (de)
BG (1) BG66121B1 (de)
BR (1) BR0115344A (de)
CA (1) CA2428642C (de)
CZ (1) CZ20031657A3 (de)
DE (1) DE60144395D1 (de)
EA (1) EA005163B1 (de)
EC (1) ECSP034573A (de)
EE (1) EE200300232A (de)
GB (1) GB0027779D0 (de)
HR (1) HRP20030377A2 (de)
HU (1) HUP0301619A3 (de)
IL (2) IL155568A0 (de)
MX (1) MXPA03004161A (de)
MY (1) MY129838A (de)
NO (1) NO20032143L (de)
NZ (1) NZ526280A (de)
PL (1) PL206783B1 (de)
SK (1) SK5792003A3 (de)
TW (1) TWI292782B (de)
UA (1) UA75102C2 (de)
UY (1) UY27020A1 (de)
WO (1) WO2002040650A2 (de)
YU (1) YU36103A (de)
ZA (1) ZA200303547B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
US6955910B2 (en) 2000-11-14 2005-10-18 Boehringer Ingelheim International Gmbh Method for large scale production of recombinant DNA-derived TPA or K2S molecules
IL190184A0 (en) 2008-03-16 2009-02-11 Hadasit Med Res Service tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
US6027888A (en) * 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
US20020061576A1 (en) * 1997-05-28 2002-05-23 Paul A. Moore Tissue plasminogen activator-like protease
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
GB0027782D0 (en) * 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes

Also Published As

Publication number Publication date
AR031334A1 (es) 2003-09-17
IL155568A (en) 2010-02-17
HUP0301619A2 (hu) 2003-09-29
YU36103A (sh) 2006-05-25
UA75102C2 (en) 2006-03-15
HUP0301619A3 (en) 2006-11-28
EE200300232A (et) 2003-10-15
BR0115344A (pt) 2003-08-26
GB0027779D0 (en) 2000-12-27
HK1070097A1 (zh) 2005-06-10
WO2002040650A2 (en) 2002-05-23
ECSP034573A (es) 2003-05-26
CA2428642A1 (en) 2002-05-23
UY27020A1 (es) 2002-07-31
DE60144395D1 (de) 2011-05-19
KR20030059252A (ko) 2003-07-07
NO20032143D0 (no) 2003-05-13
PL206783B1 (pl) 2010-09-30
CZ20031657A3 (cs) 2003-10-15
WO2002040650A3 (en) 2003-12-31
CN100567495C (zh) 2009-12-09
EP1407030A2 (de) 2004-04-14
CA2428642C (en) 2010-03-30
KR100856346B1 (ko) 2008-09-04
AU2181502A (en) 2002-05-27
HRP20030377A2 (en) 2005-04-30
AU2002221815B2 (en) 2007-08-23
IL155568A0 (en) 2003-11-23
ZA200303547B (en) 2004-05-10
MY129838A (en) 2007-05-31
BG107780A (bg) 2004-02-27
MXPA03004161A (es) 2004-04-20
TWI292782B (en) 2008-01-21
JP2004520018A (ja) 2004-07-08
PL361881A1 (en) 2004-10-04
SK5792003A3 (en) 2004-01-08
EA200300502A1 (ru) 2003-12-25
CN1541271A (zh) 2004-10-27
BG66121B1 (bg) 2011-05-31
EA005163B1 (ru) 2004-12-30
EP1407030B1 (de) 2011-04-06
NZ526280A (en) 2006-02-24
ATE504652T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
DE60139122D1 (de) Verfahren zur produktion von natürlichen medizin präparaten
NO20024319L (no) Fremgangsmåte og anordning for syretilsetning av hydrokarbonkilder
NO20024005L (no) Pteridinforbindelser for behandling av psoriasis
NO20042159L (no) Cellokulturprosess
NO20015156D0 (no) 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
NO20030002L (no) Katalysator og fremgangsmate for fremstilling av hydrokarboner
NO20032822L (no) Fremgangsmate for konsentrering av brukt syre
DE69822473D1 (de) Lipid-polyamid-konjugate und zusammensetzungen zur verabreichung von nucleinsäuremolekülen
DE69637579D1 (de) Methode zur Amplifizierung von Nukleinsäure und entsprechende Regenzien dafür
DE50114998D1 (de) Verfahren zur herstellung von monolithischen chromatographiesäulen
DE50101924D1 (de) Multiplex-sequenzierungsverfahren
ID27270A (id) Aparatus pemroses informasi program siaran
ATE277194T1 (de) Silicatein-vermittelte synthese von amorphen silikaten und siloxanen und ihre verwendung
FI970832A0 (fi) Biologisen materiaalin, kuten nukleiinihapon, erottamiseen käytettävä laite
NO20022282L (no) Fremgangsmåte for fremstilling av biopolymerer av nitrogenfattig avlöpsvann
NO20032143L (no) Fremgangsmate for produksjon i stor skala av rekombinant DNA-avledede TPA- eller K2S-molekyler
DK1082423T3 (da) Cyclin E2-gener og -proteiner
NO20024413D0 (no) Fremgangsmåte for tilvirkning og bruk av mikrogrupper av biologiske materialer
DE60007547D1 (de) 15-hydroxyeicosatetraensäure verwandte verbindungen und anwendungsverfahren
DE60226931D1 (de) Verfahren zur Herstellung von Polyester, Verfahren zur Herstellung von substituierter alpha-Hydroxycarbonsäure und Clostridium beijerinckii-Stamm HICA432
ATE301664T1 (de) Boronsäurehaltige reagenzien und oligonukleotide
DE50111597D1 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung
DE10084644T1 (de) Computernavigationshilfe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application